It is a food and beverages private limited company based in Thane, Maharashtra, India, established in 2020.
2020 | Thane, Maharashtra, India | ActiveMedioath Pharmaceuticals Private Limited, a active private limited company, was established on 17 September 2020 in Thane, Maharashtra, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304MH2020PTC346230. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Minakshi Kaira (Director), Renu Singh Kaira (Director). Past directors included Manish Kumar Pathak, Champa Kaida, Chander Singh Kaira. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 3, Ground Floor, Building No 26-B, Rajdeep Brindavan Chs Ltd, Brindavan Complex, Thane West, Thane, Maharashtra, 400601.
U24304MH2020PTC346230
346230
17 September 2020
₹1.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medioath Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Minakshi Kaira | Director | 06 Aug 2023 | Current |
| Renu Singh Kaira | Director | 30 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2023 | Past |
| Pramod Abcsdd | Director | 03 Nov 2022 | Past |
| Pramod Abcsdd | Director | 03 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medioath Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 209.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1759.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medioath Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Medioath Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medioath Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medioath Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medioath Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Medioath Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Minakshi Kaira was appointed as a Director was appointed as a Director on 06 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
The activity Renu Singh Kaira was appointed as a Director was appointed as a Director on 30 Aug 2021 & has been associated with this company since 4 years 4 months . was completed.
Medioath Pharmaceuticals Private Limited was registered on 17 Sep 2020 with Roc Mumbai & aged 5 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Medioath Pharmaceuticals Private Limited is U24304MH2020PTC346230.
Medioath Pharmaceuticals Private Limited is headquartered at Flat No 3, Ground Floor, Building No 26-B, Rajdeep Brindavan Chs Ltd, Brindavan Complex, Thane West, Thane, Maharashtra, 400601.
Medioath Pharmaceuticals Private Limited was incorporated on 17 September 2020.
The current directors of Medioath Pharmaceuticals Private Limited are
The primary industry of Medioath Pharmaceuticals Private Limited is Food And Beverages.
Medioath Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medioath Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medioath Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX